www.chochp.sk - Boehringer Ingelheim - researching, developing, manufacturing and marketing of pharmaceuticals | Katalóg dedo.sk

www.chochp.sk - Boehringer Ingelheim - researching, developing, manufacturing and marketing of pharmaceuticals

Boehringer Ingelheim - researching, developing, manufacturing and marketing of pharmaceuticals // Boehringer Ingelheim ranks among the world // pharmaceutical companies, pharmaceutical jobs, Boehringer Ingelheim, Ingleheim, pharma, animal health, consumer health care, R&D, prescription medicines, biopharmaceuticals, journalists, news releases, Annual Press Conference 2006, facts&figures 2005, clinical trials, Corporate responsibility, research, careers, licensing, job seekers, caring culture, CHC, AH, PM, BI

URL adresa: http://www.chochp.sk

Doplňujúce informácie o webe:
UTF-8





Home Contact Site Map Search Submit Value through Innovation23 October 2014 News Corporate Profile Global Activities Corporate Responsibility Careers Research & Development Clinical Trials Medical Information Products Partnering Page content jump to main navigation jump to meta navigation Boehringer Ingelheim New resource for journalists Oncology Websites Discover oncology website Life with Lung Cancer Giotrif® Plk inhibition Our Global Activities Our Countries A-Z Albania Argentina Armenia Austria Australia Azerbaijan Bahrain Belarus Belgium Bosnia and Herzegovina Brazil Bulgaria Canada Chile China Colombia Croatia Cyprus Czech Republic Denmark Ecuador Egypt Estonia Ethiopia Finland France Georgia Germany Germany Headquarters Greece Ghana Hong Kong Hungary India Indonesia Iraq Irland Israel Italy Japan Jordan Kazakhstan Kenya Kirghizia Kuweit Latvia Lebanon Libya Lithuania Macedonia Malawi Malaysia Malta Mauritius Mexico Moldavia Montenegro The Netherlands New Zealand Nigeria Norway Oman Pakistan Peru The Philippines Poland Portugal Quatar Romania Russia Saudi Arabia Seychelles Serbia Singapore Slovakia Slovenia Somalia South Africa South Korea Spain Sudan Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Turkey Turkmenistan USA Uganda Ukraine United Arab Emirates United Kingdom Uruguay Uzbekistan Venezuela Vietnam Yemen for US residents Latest Press Releases 21.10.2014

Boehringer Ingelheim initiates global Phase III study investigating nintedanib* in patients with colorectal cancer refractory to standard treatments

-

For Ex-US and Ex-UK Media Only

20.10.2014

Winners of the 2014 European PRRS Research Award announced

16.10.2014

Boehringer Ingelheim’s OFEV™ (nintedanib*) approved by the FDA for the treatment of idiopathic pulmonary fibrosis

 

-

For media outside UK, US and Canada

30.09.2014

Boehringer Ingelheim invests €100 million: Expanded Respimat® production in Dortmund

27.09.2014

Head-to-head Phase III trial demonstrates superior progression-free survival for afatinib compared to erlotinib in patients with advanced squamous cell carcinoma of the lung

-

For Ex-US and Ex-UK Media Only

27.09.2014

Boehringer Ingelheim’s afatinib achieves primary endpoint in global Phase III study in recurrent/metastatic head and neck squamous cell cancer

-

For Ex-US and Ex-UK Media Only

Further press releases Biopharmaceuticals Manufacturing. Solutions. Partnering with us Working together Partnership with Ashoka Making More Health Activities back to top Connect with us Facebook - Company Page Pinterest - Online Pinboard Twitter - Global Channel YouTube - Our Video Channels Linkedin Mobile Website RSS Feed Job Search Accessibility Statement Terms of use Imprint RSS Feed Print Page Recommend © 2010 - 2014 Boehringer Ingelheim GmbH All rights reserved Accessibility statement Homepage Sitemap Search Contact Print ...

boehringer, global, media, ingelheim, activities, phase, cancer, search, 2014 boehringer, boehringer ingelheim, media only, phase iii, 2014 boehringer ingelheim